Columbia Asset Management Exact Sciences Corp Transaction History

Columbia Asset Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 26, 2022	SELL	$35.61 - $76.23 $101,844 - $218,017	-2,860 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $5,437 - $7,551	75 Added 2.69%	2,860 $223,000
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $34,291 - $47,139	-380 Reduced 12.01%	2,785 $266,000
Q2 2021 Aug 02, 2021	BUY	$93.66 - $139.27 $69,308 - $103,059	740 Added 30.52%	3,165 $393,000
Q1 2021 May 28, 2021	BUY	$116.57 - $155.01 $25,645 - $34,102	220 Added 9.98%	2,425 $320,000
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $26,894 - $38,372	-270 Reduced 10.91%	2,205 $292,000
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $180,477 - $252,474	2,475 New	2,475 $252,000
Q1 2020 May 14, 2020	SELL	$37.9 - $104.44 $175,098 - $482,512	-4,620 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $42,713 - $54,857	-550 Reduced 10.64%	4,620 $4.27 Million
Q3 2019 Nov 12, 2019	SELL	$90.37 - $122.49 $31,629 - $42,871	-350 Reduced 6.34%	5,170 $467,000
Q2 2019 Aug 15, 2019	BUY	$89.51 - $118.04 $73,845 - $97,383	825 Added 17.57%	5,520 $652,000
Q1 2019 May 20, 2019	BUY	$61.98 - $96.5 $290,996 - $453,067	4,695 New	4,695 $407,000

671

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

Stay updated on Columbia Asset Management with notifications on news.